key: cord-0956193-5vkqwhhy
authors: Marsico, Salvatore; Giménez, Irene Espallargas; Toledo, Santiago Javier Carbullanca; Bellido, Luis Alexandre Del Carpio; María Maiques Llácer, José; Zuccarino, Flavio
title: Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography
date: 2020-04-27
journal: Rev Esp Cardiol (Engl Ed)
DOI: 10.1016/j.rec.2020.04.013
sha: 957dad6d6839990790c909f897b6a209180e1570
doc_id: 956193
cord_uid: 5vkqwhhy

nan

J o u r n a l P r e -p r o o f Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography Infarto pulmonar secundario a tromboembolismo pulmonar en COVID-19 diagnosticado con angiotomografía computarizada pulmonar con energía dual To the Editor,

We report the cases of 2 patients from Barcelona, Spain, admitted to the emergency department of our hospital secondary to COVID-19 (formerly known as SARS-CoV-2) pneumonia, confirmed with a real-time reverse-transcription polymerase chain-reaction test 1, 2 ; both patients showed respiratory deterioration and elevated serum D-dimer levels. Figure 1 illustrates the case of a 32-year-old man, with no comorbidities or risk factors, admitted to our emergency department on day 14 after symptom onset with dry cough, asthenia, arthromyalgia, fever, and right pleuritic pain. A baseline electrocardiogram showed sinus rhythm, 97 bpm, normal PR interval (120 ms) and normal QRS complex (80 ms), aQRS 0º. QTc (Friderica) 415 mseg. Echocardiography was not performed but initial physical examination showed systemic blood pressure values of 136/79 mmHg, regular rhythm with no murmurs, present and symmetrical distal pulses, and no signs of deep vein thrombosis.

Laboratory data showed elevated ferritin levels (615 ng/mL), C-reactive protein (CRP) = 3.6 mg/dL, and increased interleukin-6 (IL-6) (144.7 pg/mL). Coagulation studies: prothrombin time (PT) 12 seconds, international normalized ratio 1.1, partial thromboplastin time (aPTT) 28.2 seconds. Lupus anticoagulant testing was positive. Immunoglobulin G and immunoglobulin M anticardiolipin antibodies were also tested with a negative result. D-dimer levels were elevated up to 2460 ug/L and therefore, due to high suspicion of pulmonary thromboembolism, dual-energy pulmonary computed tomography (CT) angiography (CTPA) was performed. CTPA confirmed bilateral thromboembolism associated with multiple opacities compatible with viral pneumonia (figure 1A,B). Iodine map images showed a triangular peripheral pulmonary infarction (figure 1C).

The patient received therapy with hydroxychloroquine at a loading dose of 400 mg on the first day followed by a maintenance dose of 200 mg/d for the next 4 days. Azithromycin 500 mg/d for 3 days and enoxaparin 80 mg/12 h for 10 days were also prescribed. Throughout the admission, the patient showed clinical improvement with no respiratory support requirements, maintaining oxygen saturation levels around 97% to 99% on room air. On the 10th day after admission, 24 days after symptom onset, the patient was discharged with good health status and was asymptomatic. Given the positivity to lupus anticoagulant autoantibodies, thrombophilia testing will be performed in 3 months. A full-dose anticoagulation regimen (80 mg/12 h) was prescribed for 6 months. 

CT imaging features of 2019 novel coronavirus

CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia

COVID-19 Complicated by Acute Pulmonary Embolism. Radiology: Cardiothoracic Imaging

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Diagnostic Accuracy of Dual-Energy CT in Detection of Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis